Stonx
Market Closed
Tomorrow 9:30 AM ET
Crypto Market Open
24/7 Trading
•
CO

COSM

Cosmos Holdings Inc. Common Stock

yahoo
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
--

Price Chart

Market Cap
19.42M
Volume
2.05M
52W High
$1.32
52W Low
$0.28
Open
$0.00
Prev Close
$0.50
Day Range
0.00 - 0.00

About Cosmos Holdings Inc. Common Stock

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

Latest News

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
GlobeNewswire Inc.•Oct 10
Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
GlobeNewswire Inc.•Oct 3
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
GlobeNewswire Inc.•Sep 22
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
GlobeNewswire Inc.•Sep 11
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
GlobeNewswire Inc.•Aug 18
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
GlobeNewswire Inc.•Apr 30
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
Benzinga•Sep 16
Cosmos Health secures new pharma manufacturing deals - Investing.com
Investing.com•Jul 18